Gene expression profiling and transplantation tolerance in the clinic

Area of Science:

• Transplantation immunology
• Genomics
• Biomarker discovery

Background:

• Stable graft function without immunosuppressive therapy (IS) occurs in some kidney and liver transplant recipients.
• Identifying these "operationally tolerant" individuals is crucial for advancing IS minimization strategies.
• Gene expression profiling has emerged as a promising tool for characterizing transplant tolerance.

Purpose of the Study:

• To review the current literature on using transcriptional biomarkers for identifying clinical transplantation tolerance.
• To discuss the potential and limitations of employing gene expression profiling in this context.

Main Methods:

• Review of existing studies on gene expression profiling in transplantation tolerance.
• Analysis of transcriptional biomarkers associated with stable graft function post-transplant.
• Evaluation of the clinical applicability and challenges of biomarker-based tolerance identification.

Main Results:

• Gene expression profiling has shown potential in distinguishing tolerant from non-tolerant transplant recipients.
• Specific transcriptional signatures are associated with successful outcomes in the absence of IS.
• The identified biomarkers require further validation for widespread clinical use.

Conclusions:

• Transcriptional biomarkers offer a promising avenue for identifying operational tolerance in transplant recipients.
• Further research and validation are necessary to overcome limitations and implement these biomarkers clinically.
• Successful identification of tolerant patients could significantly impact immunosuppression management and patient outcomes.